Publications by authors named "H Carmona"
Deep brain stimulation in Latin America in comparison with the US and Europe in a real-world population: indications, demographics, techniques, technology, and adverse events.
J Neurosurg
December 2024
Article Synopsis
- This study aimed to compare deep brain stimulation (DBS) procedures in Latin America with those in the US and Europe, focusing on indications, demographics, adverse events, technology, and patient outcomes based on data from the Medtronic Product Surveillance Registry as of July 2021.
- In total, 2,912 patients were part of the registry, with notable findings that Parkinson's disease was the most common indication for DBS, while dystonia was second in Latin America, and patients in Latin America were generally 10 years younger at the time of surgery.
- The study revealed significant differences in device use, such as a higher prevalence of rechargeable batteries in Latin America (72.37% vs
Health inequities are prevalent in our medical institutions and result in unfair access to and delivery of health care. Some of the most profound health disparities are related to race, which has erroneously been used to make biological inferences to explain disease states in medicine. Our profession continues to shift away from such race-based medical narratives, which do not examine how social determinants of health, social injustice, systemic racism, and existing power structures shape health outcomes toward a health equity mindset and race-conscious medicine.
View Article and Find Full Text PDFIntroduction: Bedside cardiac assessment (BCA) is deficient across a spectrum of noncardiology trainees. Learners not taught BCA well may become instructors who do not teach well, creating a self-perpetuating problem. To improve BCA teaching and learning, we developed a high-quality, patient-centered curriculum for medicine clerkship students that could be flexibly implemented and accessible to other health professions learners.
View Article and Find Full Text PDFBackground: Although CoronaVac was the only Covid-19 vaccine adopted in the first months of the Brazilian vaccination campaign, randomized clinical trials to evaluate its efficacy in elderly adults were limited. In this study, we use routinely collected surveillance and SARS-CoV-2 vaccination and testing data comprising the population of the fifth largest city of Brazil to evaluate the effectiveness of CoronaVac in adults 60+ years old against severe outcomes.
Methods: Using large observational databases on vaccination and surveillance data from the city of Fortaleza, Brazil, we defined a retrospective cohort including 324,302 eligible adults aged ≥60 years to evaluate the effectiveness of the CoronaVac vaccine.